Questions over anticoagulant-use in elderly AF patients
Benefit of the drugs dropped to negligible levels between 87 and 92, study reports
A more cautious approach to anticoagulant therapy is needed in elderly patients with atrial fibrillation as the benefits in those with comorbidities are likely over-estimated, US research suggests.
The finding contradicts Australian recommendations that advise treatment with anticoagulants for AF even in those aged over 85.
